NXGL Stock Analysis: Buy, Sell, or Hold?

NXGL - NexGel, Inc Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$0.33
-0.06 (-14.79%) β–Ό
5d: -41.59%
30d: -23.26%
90d: -38.32%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 18, 2026 0d

Get Alerted When NXGL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NXGL is down 41.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$2.75
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.71
80.6% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NXGL is currently trading at $0.33, which is considered oversold relative to its 30-day fair value range of $0.39 to $0.49. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.8) compared to its historical average (4.9). Remarkably, the market is currently pricing in an annual earnings decline of 44.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, NXGL is in a strong downtrend. Immediate support is located at $0.30, while resistance sits at $0.59. Short-term momentum is weak, with the stock down 14.8% recently.

Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+506.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.39 - $0.49
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.8%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (50/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-14.8%)
  • BULLISH: Trading 506.1% below Wall St target ($2.00)
  • WARNING: Composite score 44/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.39 - $0.49
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.30
Resistance Level $0.59
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 0.82
Wall Street Target $2.00 (+506.1%)
Revenue Growth (YoY) 27.8%
Profit Margin -51.3%
Valuation Discount vs History -44.8% cheaper
PE vs Historical 0.8 vs 4.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -44.8% (market-implied from PE analysis)
1-Year Target $0.30 (-10%)
2-Year Target $0.27 (-19%)
3-Year Target $0.24 (-27%)
3-Yr Target (if PE normalizes) (PE: 1β†’5) $1.43 (+333%)
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.8 to 4.9
Stabilization Target: $1.96 (+493.9%)
PE Expansion Potential: +493.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NXGL.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$478 46 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$85 37 SELL
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$405 66 BUY
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 45 HOLD
RMD
ResMed Inc
BUY
19 analysts
$246 41 HOLD

More Analysis for NXGL

NXGL Technical Chart NXGL Price Prediction NXGL Earnings Date NXGL Investment Advisor NXGL Fair Price Analyzer NXGL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals